Last updated: March 21, 2022
Sponsor: Gala Therapeutics, Inc.
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chronic Bronchitis
Bronchitis
Copd (Chronic Obstructive Pulmonary Disease)
Treatment
N/AClinical Study ID
NCT04182841
CS005
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient has moderate to severe Chronic Bronchitis
Exclusion
Exclusion Criteria:
- Patient has an implantable cardioverter defibrillator, pacemaker, or any otherimplantable electronic device.
- Patient has history of ventricular tachyarrhythmia or any clinically significantatrial tachyarrhythmia (i.e., abnormality with vital signs) and/or history of type IIsecond or third degree AV block.
- Patient has airway stent(s), valves, coils, or other lung implant/prosthesis.
Study Design
Total Participants: 100
Study Start date:
January 09, 2020
Estimated Completion Date:
December 15, 2025
Study Description
Connect with a study center
Otto Wagner Spital
Wien, A-1140
AustriaActive - Recruiting
Pneumologie Thoraxklinik Heidelberg gGmbH University of Heidelberg
Heidelberg, Baden-Württemberg 69047
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.